Ortho-Clinical Kills Alzheimer s License with SynX

genomeweb
360dx

Ortho-Clinical Kills Alzheimer s License with SynX

Mar 05, 2004

NEW YORK, March 5 (GenomeWeb News) - Ortho-Clinical Diagnostics has ended an exclusive agreement to license certain Alzheimer's diagnostics technology from SynX Pharma, and has stopped trying to develop the technology, SynX said today.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Intel, Institut Curie Partner on High-Performance Computing, AI for Genomic Medicine
Strata Oncology Raises $26M in Series B Financing Round
Recessive Mutation May Cause New Neurodevelopmental Disorder
Envisagenics Wins $1.5M NIH Grant to Advance Alternative Splicing Analysis Tech
Qiagen, HTG Molecular End First Project Under CDx Development Agreement
OncoDNA, Kura Oncology Sign Patient Enrollment Pact

The Scan

Testing, Testing for Mutations

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

Hide, Nessie, Hide

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

Even More Variety

The New York Times writes about the appearance of mosaicism in healthy people.

This Week in PNAS

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.

Main menu